| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFE | Common Stock | Tax liability | $1,812,743 | -43,419 | -12% | $41.75 | 309,058 | 25 Feb 2023 | Direct | F1, F2 |
| holding | PFE | Common Stock | 4,282 | 25 Feb 2023 | By Rule 16b-3 Plan |
| Id | Content |
|---|---|
| F1 | The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon). |
| F2 | Price is the closing price of Pfizer common stock on February 24, 2023. |